Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Allscripts Purchases Eclipsys in a Major Deal in the EMR Market

By HospiMedica International staff writers
Posted on 24 Jun 2010
Allscripts (Chicago, IL, USA), a leader in the physician electronic medical record (EMR) market, has purchased rival Eclipsys (Atlanta, GA), in an all-stock deal valued at about US$1.3 billion, in what is seen as a plausible attempt to unite the EMR market. More...


The Allscripts EMR software is primarily directed towards physicians' practices and post-acute organizations, claiming 180,000 physician clients. The Eclipsys purchase adds almost 1,500 hospital and nearly 10,000 nursing and other healthcare facilities customers. The combined company still faces several challenges, including the blending of their software offerings, as well as competition from other major EMR companies such as McKesson, Cerner (Kansas, MO, USA), and GE Healthcare. Allscripts CEO Glen Tullman will serve as CEO of the combined company, while Eclipsys' President and CEO Phil Pead will take the chairman's title. The combined company will have 5,500 employees.

"It's logical to match these companies up since Allscripts has physicians and Eclipsys reaches into hospitals and health systems market,” said Bruce Carlson, Publisher of Kalorama Information (New York, NY, USA). "Despite Allscript's name recognition in the physician market, it would have been hard for any company to maintain leadership in EMR without reaching into the hospital space as well. It's not easy to break into the hospital EMR market, so an acquisition was the logical play here.”

The combined company will be better positioned to win access to the $30 billion of stimulus federal funds designated for the adoption of electronic healthcare records, an incentive created by the Obama administration to induce doctors and hospitals to move to electronic recordkeeping, with subsidies available from 2011.

Related Links:

Allscripts
Eclipsys
Kalorama Information




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.